SPY312.23+1.71 0.55%
DIA258.42+1.11 0.43%
IXIC10,207.63+53.00 0.52%

uniQure Announces A Licensing Agreement With CSL Behring To Commercialize Its Hemophilia B Gene Therapy; The Company Will Receive $2B

Benzinga · -